Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms - Anna B. Halpern; Megan Othus; Emily M. Huebner; Bart L. Scott; Paul C. Hendrie; Mary-Elizabeth M. Percival; Pamela S. Becker; Heather A. Smith; Vivian G. Oehler; Johnnie J. Orozco; Ryan D. Cassaday; Kelda M. Gardner; et al. (Haematologica, 2019)